HMGA2 and colorectal cancer: Rather, an antihelminthic drug niclosamide has been repurposed and is selective against HMGA2-overexpressing colorectal cancer cells, reversing the HMGA2-driven gene signature, and inhibiting cell cycle-related genes in these cells [193].